- Headquarters
- Lund
- Founded
- 2018
- Business Model
- B2B
- Website
- asgardthx.com
- Total Funding
- $39.7M
- Last Round
- $32.8M Series AMar 2024
- Rounds
- 2
About
Oncology (IO & targeted)
Summary
Asgard Therapeutics is a Biotech company based in Lund, Sweden, founded in 2018. It has raised $39.7M in total across 2 rounds, most recently a $32.8M Series A round in Mar 2024. Investors include Novo Holdings A/S, Boehringer Ingelheim Venture Fund and Industrifonden.
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
Novel bicyclic peptides and drug conjugates for cancer
Clinical-stage biopharmaceutical company founded in 2015 developing best-in-class cancer therapeu...
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...